REZAMID- sulfur and resorcinol lotion 
Summers Laboratories Inc

----------

SUMMERS LABS (as PLD) - REZAMID (11086-022)

ACTIVE INGREDIENTS

SULFUR 5%

RESORCINOL 2%

PURPOSE

ACNE TREATMENT LOTION

USE

DRIES UP ACNE PIMPLES, HELPS PREVENT NEW PIMPLES

WARNINGS

DO NOT USE

WHEN USING THIS PRODUCT

STOP USE AND ASK A DOCTOR IF

KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

DIRECTIONS

INACTIVE INGREDIENTS

water, SD-40 alcohol 28%, zinc oxide, talc, titanium dioxide, propylene glycol, attapulgite, lauramide DEA, iron oxides, sodium bisulfite, PEG-8 laurate, parachlorometaxylenol, hydroxyethylcellulose, sodium chloride, sodium polynapthalene sulfonate, EDTA, methyl paraben, xanthan gum, butylparaben, fragrance, simethicone.

Rezamid_Unit Carton

REZAMID 
sulfur and resorcinol lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11086-022
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR5 g  in 100 mL
RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK) RESORCINOL2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ALCOHOL (UNII: 3K9958V90M)  
ZINC OXIDE (UNII: SOI2LOH54Z)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
ATTAPULGITE (UNII: U6V729APAM)  
LAURIC DIETHANOLAMIDE (UNII: I29I2VHG38)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
SODIUM BISULFITE (UNII: TZX5469Z6I)  
PEG-8 LAURATE (UNII: 762O8IWA10)  
CHLOROXYLENOL (UNII: 0F32U78V2Q)  
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) (UNII: 8136Y38GY5)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM NAPHTHALENESULFONATE (UNII: D3F8YRX7TP)  
EDETIC ACID (UNII: 9G34HU7RV0)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
XANTHAN GUM (UNII: TTV12P4NEE)  
BUTYLPARABEN (UNII: 3QPI1U3FV8)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
SILICON (UNII: Z4152N8IUI)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11086-022-0156.7 mL in 1 BOTTLE; Type 0: Not a Combination Product10/30/2013
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM03210/30/2013
Labeler - Summers Laboratories Inc (002382612)

Revised: 10/2023
Document Id: 074cf888-7213-31ad-e063-6394a90a16d8
Set id: d02ace0b-7244-45d4-987f-eb569303a426
Version: 9
Effective Time: 20231009
 
Summers Laboratories Inc